“Clinical Response to Rifaximin Amongst Irritable Bowel Syndrome (IBS) Patients at Tertiary Level Hospital in Nepal”. 2024. Journal of Patan Academy of Health Sciences 11 (1): 21-26. https://doi.org/10.3126/jpahs.v11i1.65652.